Patent 7150970 was granted and assigned to University of Iowa on December, 2006 by the United States Patent and Trademark Office.
The present invention provides RNA molecules (e.g., antisense, RNAi, or siRNA) specific for VEGF-C, and further provides methods of reducing expression of VEGF-C in cells (e.g., cancer cells).